ZERO Prostate Cancer Proud to Collaborate with Prostate Cancer Foundation for the Young Investigator Award to Eliminate Health Disparities March 7, 2022 FOR IMMEDIATE RELEASEMedia Contact:Jessica Fetrowjessica.fetrow@zerocancer.org202-923-1113Award to encourage diversity in both research and researchers in the prostate cancer space Washington, D.C., March 7, 2022 - ZERO Prostate Cancer and the Prostate Cancer Foundation are proud to join forces in presenting the ZERO/PCF Young Investigator Award to Eliminate Health Disparities. Both organizations are contributing $150,000 for a combined $300,000 grant over three years toward career and project support for a young, proven investigator with an interest in prostate cancer research and a strong focus on eliminating health disparities.This award will target health disparities in prostate cancer to help eliminate the differences that exist across the prostate cancer continuum, including prevention, detection, diagnosis, treatment, survivorship, and end-of-life care.One of the most significant disparities in prostate cancer is that Black men with prostate cancer continue to face disproportionate diagnosis and mortality rates in comparison to their white counterparts. They are almost twice as likely to be diagnosed with prostate cancer than white men, and more than twice as likely to die from the disease. The goal of this grant is to empower young researchers to combat these statistics.Other disparities include economics, education, and zip codes such as care received in urban and rural America.“We can’t end prostate cancer without eliminating disparities in prostate cancer care,” Jamie Bearse, ZERO’s CEO and President said. “Not only does this joint award help but ideally it will go to a scientist who has a diverse background; increasing diversity and inclusion in the prostate cancer research field.”The ZERO/PCF Young Investigator Award to Eliminate Health Disparities is intended to encourage researchers to establish partnerships with community members, patients, and/or advocacy groups in order to identify solutions that reduce disparities and work toward achieving health equity. This includes helping the prostate cancer research community move beyond merely describing prostate cancer disparities, but to support research that explicates or intervenes on the modifiable factors that create the disparities.“Both ZERO and the Prostate Cancer Foundation are committed to encouraging research toward achieving health equity,” said Dr. Charles Ryan, PCF’s President and CEO. “This award is another step toward addressing these urgent issues.”The deadline for this year’s application is April 18, 2022 and the recipient will be announced at PCF’s Scientific Retreat this fall. To apply for the Young Investigator Award to Eliminate Health Disparities grant, please visit the application portal. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org About the Prostate Cancer FoundationThe Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has been responsible for raising close to $1 billion in support of cutting-edge research by more than 2,200 research projects at 245 leading cancer centers in 28 countries around the world. Since PCF’s inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to creating a global public square for prostate cancer, in service to our mission of ending death and suffering from the disease. Learn more at pcf.org. Press Release
ZERO Prostate Cancer Proud to Collaborate with Prostate Cancer Foundation for the Young Investigator Award to Eliminate Health Disparities March 7, 2022
FOR IMMEDIATE RELEASEMedia Contact:Jessica Fetrowjessica.fetrow@zerocancer.org202-923-1113Award to encourage diversity in both research and researchers in the prostate cancer space Washington, D.C., March 7, 2022 - ZERO Prostate Cancer and the Prostate Cancer Foundation are proud to join forces in presenting the ZERO/PCF Young Investigator Award to Eliminate Health Disparities. Both organizations are contributing $150,000 for a combined $300,000 grant over three years toward career and project support for a young, proven investigator with an interest in prostate cancer research and a strong focus on eliminating health disparities.This award will target health disparities in prostate cancer to help eliminate the differences that exist across the prostate cancer continuum, including prevention, detection, diagnosis, treatment, survivorship, and end-of-life care.One of the most significant disparities in prostate cancer is that Black men with prostate cancer continue to face disproportionate diagnosis and mortality rates in comparison to their white counterparts. They are almost twice as likely to be diagnosed with prostate cancer than white men, and more than twice as likely to die from the disease. The goal of this grant is to empower young researchers to combat these statistics.Other disparities include economics, education, and zip codes such as care received in urban and rural America.“We can’t end prostate cancer without eliminating disparities in prostate cancer care,” Jamie Bearse, ZERO’s CEO and President said. “Not only does this joint award help but ideally it will go to a scientist who has a diverse background; increasing diversity and inclusion in the prostate cancer research field.”The ZERO/PCF Young Investigator Award to Eliminate Health Disparities is intended to encourage researchers to establish partnerships with community members, patients, and/or advocacy groups in order to identify solutions that reduce disparities and work toward achieving health equity. This includes helping the prostate cancer research community move beyond merely describing prostate cancer disparities, but to support research that explicates or intervenes on the modifiable factors that create the disparities.“Both ZERO and the Prostate Cancer Foundation are committed to encouraging research toward achieving health equity,” said Dr. Charles Ryan, PCF’s President and CEO. “This award is another step toward addressing these urgent issues.”The deadline for this year’s application is April 18, 2022 and the recipient will be announced at PCF’s Scientific Retreat this fall. To apply for the Young Investigator Award to Eliminate Health Disparities grant, please visit the application portal.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
About the Prostate Cancer FoundationThe Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has been responsible for raising close to $1 billion in support of cutting-edge research by more than 2,200 research projects at 245 leading cancer centers in 28 countries around the world. Since PCF’s inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to creating a global public square for prostate cancer, in service to our mission of ending death and suffering from the disease. Learn more at pcf.org.
